about
Spread of artemisinin resistance in Plasmodium falciparum malariaChanges in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deploymentEmergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal studyArtesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trialEvaluation of the Wayson stain for the rapid diagnosis of melioidosisClinical determinants of early parasitological response to ACTs in African patients with uncomplicated falciparum malaria: a literature review and meta-analysis of individual patient dataA multi-center randomised controlled trial of gatifloxacin versus azithromycin for the treatment of uncomplicated typhoid fever in children and adults in VietnamOseltamivir is adequately absorbed following nasogastric administration to adult patients with severe H5N1 influenzaDefining the in vivo phenotype of artemisinin-resistant falciparum malaria: a modelling approachExperimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical TrialStudying the effectiveness of activated carbon R95 respirators in reducing the inhalation of combustion by-products in Hanoi, Vietnam: a demonstration studyBayesian hierarchical regression on clearance rates in the presence of "lag" and "tail" phases with an application to malaria parasites.The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient dataBaseline data of parasite clearance in patients with falciparum malaria treated with an artemisinin derivative: an individual patient data meta-analysis.Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial.An open randomized comparison of gatifloxacin versus cefixime for the treatment of uncomplicated enteric fever.The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosisClinical diagnosis and assessment of severity of confirmed dengue infections in Vietnamese children: is the world health organization classification system helpful?Safety and efficacy of dihydroartemisinin-piperaquine in falciparum malaria: a prospective multi-centre individual patient data analysis.Molecular correlates of high-level antifolate resistance in Rwandan children with Plasmodium falciparum malaria.Entomological determinants of insecticide-treated bed net effectiveness in Western Myanmar.Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria.Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults.Open-label randomized trial of oral trimethoprim-sulfamethoxazole, doxycycline, and chloramphenicol compared with trimethoprim-sulfamethoxazole and doxycycline for maintenance therapy of melioidosis.Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patientsPolymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine.Comparability of tympanic and oral mercury thermometers at high ambient temperaturesA phase III, randomized, non-inferiority trial to assess the efficacy and safety of dihydroartemisinin-piperaquine in comparison with artesunate-mefloquine in patients with uncomplicated Plasmodium falciparum malaria in southern Laos.Comparison of three fluid solutions for resuscitation in dengue shock syndrome.Two randomized controlled trials of ceftazidime alone versus ceftazidime in combination with trimethoprim-sulfamethoxazole for the treatment of severe melioidosis.Risk factors for recurrent melioidosis in northeast Thailand.Population pharmacokinetic assessment of a new regimen of mefloquine used in combination treatment of uncomplicated falciparum malaria.In vivo parasitological measures of artemisinin susceptibilityAssessment of therapeutic responses to gametocytocidal drugs in Plasmodium falciparum malariaAn open-label crossover study to evaluate potential pharmacokinetic interactions between oral oseltamivir and intravenous zanamivir in healthy Thai adults.Beijing genotype of Mycobacterium tuberculosis is significantly associated with human immunodeficiency virus infection and multidrug resistance in cases of tuberculous meningitis.Population pharmacokinetics of artesunate and amodiaquine in African childrenA multi-center, open-label trial to compare the efficacy and pharmacokinetics of Artemether-Lumefantrine in children with severe acute malnutrition versus children without severe acute malnutrition: study protocol for the MAL-NUT studyEstimation of gestational age from fundal height: a solution for resource-poor settings.Poor quality vital anti-malarials in Africa - an urgent neglected public health priority.
P50
Q21032481-3862CFB6-4532-46DC-9D28-515651D0B2F8Q21090072-5156B46C-3692-42EB-9EAB-FC85CA9EA4DDQ24598695-A25538B4-1534-4956-9AB0-616656ED7AFAQ24630683-8889649D-BF7B-4720-865D-00FF18CFDE1CQ24672567-C440FE8A-8875-401B-B1FA-8BE307C3FE6CQ26783902-72B1EA1B-D9AA-4BF3-8890-2661C0D40DE2Q28472731-0878C420-6764-4C8A-B2CC-7753D01235ECQ28473860-E502049A-001C-46D2-A6A1-5441641EC505Q28546794-1D27F288-8B74-4E18-AFD8-004EA5C3D1BFQ28551448-4E95EBD4-83D1-4AE5-A78B-A2B80106E6A6Q28710142-CE02FB7C-B644-445D-A8A8-79CE2FF3FD32Q30664891-1D31810F-08B9-4341-8F29-11313E663D6FQ30936416-98800117-CAB1-4A45-BDFE-4356739C4E8DQ30995133-CBC0C10A-5522-4E06-A8A5-295E0949C7D6Q33222370-1742EF07-2D1D-4FA2-A567-4262D3D30C73Q33288953-7980290B-AB03-46A9-934E-5EBA6696E578Q33325926-95A11DE0-C201-42A2-93B0-69E705E63601Q33359806-E285F91D-5162-4C01-B13D-00890948949BQ33489551-2C532D7F-DBDF-4D74-B9DC-3F9B33F14B3AQ33559071-7EE2F373-FCEF-4B00-B569-13B635DBCC03Q33589131-CC6F339E-F423-4A52-8B5B-E013B5FBDE52Q33903438-2D1F72F3-90C7-4163-88A9-2F7C3BE35E48Q33982474-2F580BE7-5DB6-45A3-990D-8C4813AE4517Q34077038-7FB6C16B-D654-490E-A455-7AF9FFF04E9DQ34247688-3AB074EC-8900-4E6B-81DF-63C93FAC7477Q34281680-365CAF3F-27D8-47EF-81C5-DD2E9F9F482CQ34338726-3F0B2F3F-8618-437B-9C72-892951B6CF34Q34341784-AB81EA05-DCCD-4ACB-B3A2-2B399A0C0B4FQ34447478-4583297F-DB51-4FF9-BE63-3036AA3AD9BFQ34451065-10FF44E1-B46C-437C-9361-6CD6ED09879CQ34567077-2CEA358E-0FB9-4154-AA70-D8D5161A7996Q34721496-AF034899-F92D-4D2B-A8D5-503C03E2F4EEQ34921155-7609A5FC-19AF-4FB2-9D45-5BB860AE22AAQ34968407-DAD171A0-64A5-4B42-9F42-E63380D0403CQ35191600-9EDFD14C-92E2-4B9F-8E53-9659C0FF6C00Q35220932-A774D153-F3D9-4EA9-AE58-C6048B4B7F41Q35575394-FAFD38C1-3D19-4FEF-BE10-21C45BA93A41Q35661786-0CE62B7C-E9F7-4AA7-AD32-0338A2032846Q35684073-F32A4BCD-7D09-4005-90B9-6E23B67F500BQ35685124-78CCA68C-AB3B-45A3-A42B-2E718A343A95
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Kasia Stepniewska
@ast
Kasia Stepniewska
@en
Kasia Stepniewska
@es
Kasia Stepniewska
@nl
Kasia Stepniewska
@sl
type
label
Kasia Stepniewska
@ast
Kasia Stepniewska
@en
Kasia Stepniewska
@es
Kasia Stepniewska
@nl
Kasia Stepniewska
@sl
prefLabel
Kasia Stepniewska
@ast
Kasia Stepniewska
@en
Kasia Stepniewska
@es
Kasia Stepniewska
@nl
Kasia Stepniewska
@sl